Albumin & Creatinine Tests Market Outlook:
Albumin & Creatinine Tests Market size was valued at USD 5.65 billion in 2025 and is likely to cross USD 32.45 billion by 2035, registering more than 19.1% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of albumin & creatinine tests is assessed at USD 6.62 billion.
The growth of the market can be attributed to the increasing cases of kidney diseases and disorders worldwide. Kidney disease is a serious medical condition that can lead to kidney failure. As per the Centers for Disease Control and Prevention (CDC), more than 1 in 7 adults i.e., 37 million people, suffered from chronic kidney disease in 2021. A variety of urine analysis procedures and products are available to detect such disease, which include multiple kidney treatments as well as regular blood examinations of components such as creatinine, albumin, and the ACR ratio. Urine analysis can provide information about the presence of kidney diseases. It can also help to monitor the progression of kidney diseases and assess the effectiveness of treatment.
Additionally, other factors that are anticipated to contribute to the growth of the global albumin tests and creatinine tests market include the increasing awareness of early disease detection among people and the growing preference for home testing for regular monitoring. Additionally, innovations in urine analysis testing is anticipated to contribute to the growth of the market. For instance, Minuteful Kidney is a smartphone-based, home kidney function testing service that is convenient and affordable. The test is easy to use and can be done at home without visiting a doctor. It can be done regularly to help people with diabetes or high blood pressure monitor their kidney health. The result of the patient's test is automatically recorded in the app's electronic medical record, and it is automatically sent to their healthcare practitioner for further action.
